DXR
Daxor Corporation · NASDAQ · Healthcare · USD · 10-K for 2011, filed 2012-03-28
Figures on this page computed 2026-11-08 12:43 UTC
Last close
8.91USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2011, filed 2012-03-28
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2011
- Accession
- 0001019056-12-000401
- Reported in
- USD
- computed
- 10-K for 2011, filed 2012-03-28
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2011
- Accession
- 0001019056-12-000401
- Reported in
- USD
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
-496.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2011
- Accession
- 0001019056-12-000401
- Reported in
- USD
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
-458.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2011
- Accession
- 0001019056-12-000401
- Reported in
- USD
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2011
- Accession
- 0001019056-12-000401
- Reported in
- USD
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
n/aDividend yield
The stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- Computed from the filing for 2010
What it pays out is the furthest below its sector's middle: 0.04 against 0.50 on the market's range.
What it sells, to whom
lens 8 of 9The filer tagged nothing for this, so there is nothing filed to draw.
Nothing is drawn in its place. The other lenses are unaffected.
No concentration of risk disclosure was tagged in this filing and no concentration note was tagged either. That is not a statement that the company has no concentration.